ICUI.NASDAQIcu Medical Inc/de

Form 4: ICU Medical CFO Brian Bonnell Reports Stock Transactions

Sentiment:

SEC Form 4

📋All filings for Icu Medical Inc/de
🔒Login to Follow

Brian Bonnell, CFO of ICU Medical, reports the acquisition and disposal of common stock and derivative securities, including Restricted Stock Units and Performance-based Restricted Stock Units, on March 7th and 8th, 2024.

Summary

  • Brian Bonnell, the Chief Financial Officer of ICU Medical, filed a Form 4 detailing changes in beneficial ownership.
  • On March 7th and 8th, 2024, Bonnell engaged in transactions involving common stock, Restricted Stock Units (RSUs), and Performance-based Restricted Stock Units (PRSUs).
  • These transactions included the acquisition of common stock through the vesting of RSUs and PRSUs, as well as the disposal of common stock to cover tax obligations.
  • On March 7th, 2,145 RSUs and 12,872 PRSUs vested, resulting in the acquisition of the same number of common stock shares.
  • Also on March 7th, 1,175 and 7,059 shares of common stock were disposed of at a price of $105.39.
  • On March 8th, 2,210 RSUs and 7,289 PRSUs vested, resulting in the acquisition of the same number of common stock shares.
  • Also on March 8th, 1,212 and 3,998 shares of common stock were disposed of at a price of $104.52.
  • Following these transactions, Bonnell directly owns 23,487 shares of common stock.

Sentiment

Score: 6

Explanation: The sentiment is neutral. The document simply reports transactions, with a slight positive leaning due to the vesting of performance-based units above their original grant levels, indicating achievement of performance targets.

Positives

  • The vesting of PRSUs at above-original grant levels (200% and 110%) suggests strong performance against pre-defined metrics.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the trading activities of company insiders. These filings are closely watched by investors seeking insights into management's perspective on the company's stock.

Stakeholder Impact

  • The vesting of RSUs and PRSUs impacts shareholders by increasing the number of shares outstanding.
  • The transactions also affect the CFO's personal holdings and alignment with shareholder interests.

Key Dates

DateDescription
03/08/2021PRSUs were granted on March 8, 2021 and had a 3-Year cliff-vest subject to the satisfaction of performance-based metrics and continuous services through the vest date.
03/07/2022These PRSUs were granted on March 7, 2022 and had a 2-year cliff-vest performance period subject to the satisfaction of performance-based metrics and continuous services through the vest date.
02/2024The Compensation Committee approved for vesting in February 2024 the PRSUs at 200% of the original grant for those granted on March 7, 2022 and at 110% for those granted on March 8, 2021.
03/07/2024Transactions involving common stock, RSUs, and PRSUs occurred on March 7, 2024.
03/08/2024Transactions involving common stock, RSUs, and PRSUs occurred on March 8, 2024.
03/11/2024Date of the Form 4 filing.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.